Related references
Note: Only part of the references are listed.Corticosteroid dependent and independent effects of a cannabinoid agonist on core temperature, motor activity, and prepulse inhibition of the acoustic startle reflex in Wistar rats
Avdesh Avdesh et al.
PSYCHOPHARMACOLOGY (2012)
Cannabis use and sensorimotor gating in patients with schizophrenia and healthy controls
Kirsty E. Scholes-Balog et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2011)
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
Antonio Ortega-Alvaro et al.
NEUROPSYCHOPHARMACOLOGY (2011)
AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents
Mark D. Black et al.
PSYCHOPHARMACOLOGY (2011)
Cannabinoids Modulate Hippocampal Memory and Plasticity
Hila Abush et al.
HIPPOCAMPUS (2010)
FACILITATION OF ENDOCANNABINOID EFFECTS IN THE VENTRAL HIPPOCAMPUS MODULATES ANXIETY-LIKE BEHAVIORS DEPENDING ON PREVIOUS STRESS EXPERIENCE
A. C. Campos et al.
NEUROSCIENCE (2010)
Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia
K. E. Scholes et al.
PSYCHOLOGICAL MEDICINE (2010)
Hippocampal CB1 Receptors Mediate the Memory Impairing Effects of Δ9-Tetrahydrocannabinol
Laura E. Wise et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Alterations to pre-pulse inhibition (PPI) in chronic cannabis users are secondary to sustained attention deficits
Kirsty Elizabeth Scholes et al.
PSYCHOPHARMACOLOGY (2009)
Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond
Roger G. Pertwee
ADDICTION BIOLOGY (2008)
Differential response to a selective cannabinoid receptor antagonist (SR141716: rimonabant) in female mice from lines selectively bred for high voluntary wheel-running behaviour
Brooke K. Keeney et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Short- and long-term effects of cannabinoids on the extinction of contextual fear memory in rats
Fabricio A. Pamplona et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)
Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats
Nico Wegener et al.
PSYCHOPHARMACOLOGY (2008)
Cannabinoid CB1 receptor inverse agonists and neutral antagonists:: Effects on food intake, food-reinforced behavior and food aversions
John D. Salamone et al.
PHYSIOLOGY & BEHAVIOR (2007)
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia
Darryl T. Hamamoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The acute effects of cannabinoids on memory in humans: a review
Mohini Ranganathan et al.
PSYCHOPHARMACOLOGY (2006)
Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: Further evidence for an anxiolytic role for endogenous cannabinoid signaling
Sachin Patel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors
FA Pamplona et al.
NEUROSCIENCE LETTERS (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
T-maze alternation in the rodent
Robert M. J. Deacon et al.
NATURE PROTOCOLS (2006)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test
RF Genn et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
Effects of changing reward on performance of the delayed spatial win-shift radial maze task in pedunculopontine tegmental nucleus lesioned rats
CL Taylor et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats
S Marín et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2003)
Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes
JL Wiley et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2002)
Cognitive and subjective dose-response effects of acute oral Δ9-tetrahydrocannabinol (THC) in infrequent cannabis users
HV Curran et al.
PSYCHOPHARMACOLOGY (2002)
Tetrahydrocannabinol and endocannabinoids in feeding and appetite
EM Berry et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats
EM Romero et al.
DEVELOPMENTAL BRAIN RESEARCH (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Cognitive functioning of long-term heavy cannabis users seeking treatment
N Solowij et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Differing effects of the cannabinoid agonist, CP 55,940, in an alcohol or Tween 80 solvent, on prepulse inhibition of the acoustic startle reflex in the rat
CC Stanley-Cary et al.
BEHAVIOURAL PHARMACOLOGY (2002)
Neuropsychological performance in long-term cannabis users
HG Pope et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Leptin-regulated endocannabinoids are involved in maintaining food intake
V Di Marzo et al.
NATURE (2001)
Blockade of effects of smoked marijuana by the CBl-selective cannabinoid receptor antagonist SR141716
MA Huestis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats
D Braida et al.
NEUROREPORT (2000)
Share Paper
